These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 9816296)
1. Expression and activity of signaling molecules in T lymphocytes obtained from patients with metastatic melanoma before and after interleukin 2 therapy. Rabinowich H; Banks M; Reichert TE; Logan TF; Kirkwood JM; Whiteside TL Clin Cancer Res; 1996 Aug; 2(8):1263-74. PubMed ID: 9816296 [TBL] [Abstract][Full Text] [Related]
2. Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy. Bukowski RM; Rayman P; Uzzo R; Bloom T; Sandstrom K; Peereboom D; Olencki T; Budd GT; McLain D; Elson P; Novick A; Finke JH Clin Cancer Res; 1998 Oct; 4(10):2337-47. PubMed ID: 9796963 [TBL] [Abstract][Full Text] [Related]
3. Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma. Lai P; Rabinowich H; Crowley-Nowick PA; Bell MC; Mantovani G; Whiteside TL Clin Cancer Res; 1996 Jan; 2(1):161-73. PubMed ID: 9816103 [TBL] [Abstract][Full Text] [Related]
4. Differential loss of T cell signaling molecules in metastatic melanoma patients' T lymphocyte subsets expressing distinct TCR variable regions. Maccalli C; Pisarra P; Vegetti C; Sensi M; Parmiani G; Anichini A J Immunol; 1999 Dec; 163(12):6912-23. PubMed ID: 10586094 [TBL] [Abstract][Full Text] [Related]
5. Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell-and natural killer cell-mediated cytotoxicity. Kono K; Salazar-Onfray F; Petersson M; Hansson J; Masucci G; Wasserman K; Nakazawa T; Anderson P; Kiessling R Eur J Immunol; 1996 Jun; 26(6):1308-13. PubMed ID: 8647210 [TBL] [Abstract][Full Text] [Related]
6. Decreased zeta chain expression and apoptosis in CD3+ peripheral blood T lymphocytes of patients with melanoma. Dworacki G; Meidenbauer N; Kuss I; Hoffmann TK; Gooding W; Lotze M; Whiteside TL Clin Cancer Res; 2001 Mar; 7(3 Suppl):947s-957s. PubMed ID: 11300496 [TBL] [Abstract][Full Text] [Related]
7. Increased ubiquitination and reduced expression of LCK in T lymphocytes from patients with systemic lupus erythematosus. Jury EC; Kabouridis PS; Abba A; Mageed RA; Isenberg DA Arthritis Rheum; 2003 May; 48(5):1343-54. PubMed ID: 12746907 [TBL] [Abstract][Full Text] [Related]
8. Activation of naïve CD4 T cells by anti-CD3 reveals an important role for Fyn in Lck-mediated signaling. Sugie K; Jeon MS; Grey HM Proc Natl Acad Sci U S A; 2004 Oct; 101(41):14859-64. PubMed ID: 15465914 [TBL] [Abstract][Full Text] [Related]
9. Oxidative-stress-induced T lymphocyte hyporesponsiveness is caused by structural modification rather than proteasomal degradation of crucial TCR signaling molecules. Cemerski S; van Meerwijk JP; Romagnoli P Eur J Immunol; 2003 Aug; 33(8):2178-85. PubMed ID: 12884292 [TBL] [Abstract][Full Text] [Related]
10. Alterations in T cell receptor and signal transduction molecules in melanoma patients. Zea AH; Curti BD; Longo DL; Alvord WG; Strobl SL; Mizoguchi H; Creekmore SP; O'Shea JJ; Powers GC; Urba WJ Clin Cancer Res; 1995 Nov; 1(11):1327-35. PubMed ID: 9815928 [TBL] [Abstract][Full Text] [Related]
11. Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis. Gardini A; Ercolani G; Riccobon A; Ravaioli M; Ridolfi L; Flamini E; Ridolfi R; Grazi GL; Cavallari A; Amadori D J Surg Oncol; 2004 Jul; 87(1):46-52. PubMed ID: 15221919 [TBL] [Abstract][Full Text] [Related]
12. The effect of peripheral blood lymphocyte stimulation on zeta chain expression and IL-2 production in Hodgkin's disease. Frydecka I; Boćko D; Kosmaczewska A; Ciszak L; Morilla R Br J Cancer; 2001 May; 84(10):1339-43. PubMed ID: 11355944 [TBL] [Abstract][Full Text] [Related]
13. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma. Reichert TE; Strauss L; Wagner EM; Gooding W; Whiteside TL Clin Cancer Res; 2002 Oct; 8(10):3137-45. PubMed ID: 12374681 [TBL] [Abstract][Full Text] [Related]
14. Inefficient phospholipase C activation and reduced Lck expression characterize the signaling defect of umbilical cord T lymphocytes. Miscia S; Di Baldassarre A; Sabatino G; Bonvini E; Rana RA; Vitale M; Di Valerio V; Manzoli FA J Immunol; 1999 Sep; 163(5):2416-24. PubMed ID: 10452976 [TBL] [Abstract][Full Text] [Related]
15. Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus. Nambiar MP; Fisher CU; Warke VG; Krishnan S; Mitchell JP; Delaney N; Tsokos GC Arthritis Rheum; 2003 Jul; 48(7):1948-55. PubMed ID: 12847689 [TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of rosmarinic acid on Lck SH2 domain binding to a synthetic phosphopeptide. Ahn SC; Oh WK; Kim BY; Kang DO; Kim MS; Heo GY; Ahn JS Planta Med; 2003 Jul; 69(7):642-6. PubMed ID: 12898421 [TBL] [Abstract][Full Text] [Related]
17. Multiparametric flow cytometric analysis of signal transducer and activator of transcription 5 phosphorylation in immune cell subsets in vitro and following interleukin-2 immunotherapy. Varker KA; Kondadasula SV; Go MR; Lesinski GB; Ghosh-Berkebile R; Lehman A; Monk JP; Olencki T; Kendra K; Carson WE Clin Cancer Res; 2006 Oct; 12(19):5850-8. PubMed ID: 17020993 [TBL] [Abstract][Full Text] [Related]